BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1661096)

  • 1. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells.
    Durante W; Schini VB; Scott-Burden T; Junquero DC; Kroll MH; Vanhoutte PM; Schafer AI
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H2024-30. PubMed ID: 1661096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmin potentiates induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells.
    Durante W; Schini VB; Catovsky S; Kroll MH; Vanhoutte PM; Schafer AI
    Am J Physiol; 1993 Feb; 264(2 Pt 2):H617-24. PubMed ID: 8447474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C.
    Durante W; Kroll MH; Vanhoutte PM; Schafer AI
    Blood; 1992 Jan; 79(1):110-6. PubMed ID: 1309423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
    Mollace V; Salvemini D; Anggard E; Vane J
    Br J Pharmacol; 1991 Nov; 104(3):633-8. PubMed ID: 1724627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells.
    Junquero DC; Scott-Burden T; Schini VB; Vanhoutte PM
    J Physiol; 1992 Aug; 454():451-65. PubMed ID: 1282159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
    Beasley D; Schwartz JH; Brenner BM
    J Clin Invest; 1991 Feb; 87(2):602-8. PubMed ID: 1671393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosapentaenoic acid potentiates the production of nitric oxide evoked by interleukin-1 beta in cultured vascular smooth muscle cells.
    Schini VB; Durante W; Catovsky S; Vanhoutte PM
    J Vasc Res; 1993; 30(4):209-17. PubMed ID: 8357951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets inhibit the induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells.
    Durante W; Schini VB; Kroll MH; Catovsky S; Scott-Burden T; White JG; Vanhoutte PM; Schafer AI
    Blood; 1994 Apr; 83(7):1831-8. PubMed ID: 8142651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin inhibits induction of nitric oxide synthase in vascular smooth muscle cells.
    Schini VB; Catovsky S; Durante W; Scott-Burden T; Schafer AI; Vanhoutte PM
    Am J Physiol; 1993 Feb; 264(2 Pt 2):H611-6. PubMed ID: 7680540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle.
    French JF; Lambert LE; Dage RC
    J Pharmacol Exp Ther; 1991 Oct; 259(1):260-4. PubMed ID: 1717680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
    Beasley D; McGuiggin M
    J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells.
    Schini VB; Catovsky S; Schray-Utz B; Busse R; Vanhoutte PM
    Circ Res; 1994 Jan; 74(1):24-32. PubMed ID: 7505207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide.
    Salvemini D; Mollace V; Pistelli A; Anggard E; Vane J
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):982-6. PubMed ID: 1310543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation.
    Scott-Burden T; Schini VB; Elizondo E; Junquero DC; Vanhoutte PM
    Circ Res; 1992 Nov; 71(5):1088-100. PubMed ID: 1327576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation.
    Salvemini D; Masini E; Anggard E; Mannaioni PF; Vane J
    Biochem Biophys Res Commun; 1990 Jun; 169(2):596-601. PubMed ID: 1972620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells.
    Kusano E; Tian S; Umino T; Tetsuka T; Ando Y; Asano Y
    J Hypertens; 1997 Jun; 15(6):627-32. PubMed ID: 9218182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
    Marczin N; Ryan US; Catravas JD
    J Pharmacol Exp Ther; 1992 Oct; 263(1):170-9. PubMed ID: 1328604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGRP enhances induction of NO synthase in vascular smooth muscle cells via a cAMP-dependent mechanism.
    Schini-Kerth VB; Fisslthaler B; Busse R
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2483-90. PubMed ID: 7528998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-platelet agent, ticlopidine, upregulates interleukin-1-Beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
    Inoue M; Kusano E; Ito C; Akimoto T; Iimura O; Nemoto J; Amemiya M; Muto S; Asano Y
    Exp Nephrol; 2002; 10(4):267-74. PubMed ID: 12097830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism.
    Broekman MJ; Eiroa AM; Marcus AJ
    Blood; 1991 Aug; 78(4):1033-40. PubMed ID: 1868238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.